Skip to content

Behavior and Naltrexone Treatment for Alcoholics

Coping, Exposure, and Naltrexone Treatment With Alcoholics

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000449
Enrollment
160
Registered
1999-11-03
Start date
Unknown
Completion date
2000-03-31
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism

Brief summary

The study's purpose is to improve alcoholism treatment by investigating the combined effectiveness of a psychotherapy (Coping Skills Training and Cue Exposure Treatment - CSTCET) with naltrexone in a randomized clinical trial. Individuals will receive 2 weeks of CSTCET or a control treatment as inpatients followed by 12 consecutive weeks of receiving either naltrexone or placebo as outpatients. Followups at 24, 48, and 72 weeks after treatment is completed.

Interventions

BEHAVIORALcognitive behavioral therapy

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Meets criteria for alcohol dependence.

Exclusion criteria

* Current diagnosis of dependence on other substances except nicotine. * A history of psychosis or current psychotic symptoms. * Current suicidality, homocidality, or psychiatric symptoms that require additional medication. * Current use of disulfiram (Antabuse). * Evidence of significant cerebral, renal, thyroid, or cardiac disease. * History of opioid abuse in the previous year. * History of cirrhosis, hepatocellular disease, or elevated bilirubin. * Females who are pregnant, nursing, or not using a reliable method of birth control.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026